Sort
34,240 grants matching “atherosclerosis”
Transcriptional Control of Monocyte Development
$628,283Catherine C Hedrick · La Jolla Institute For Immunology · R01 · FY2018 · HL
Transcriptional Control of Monocyte Development
$628,283Catherine C Hedrick · La Jolla Institute For Immunology · R01 · FY2016 · HL
Transcriptional Control of Monocyte Development
$628,283Catherine C Hedrick · La Jolla Institute For Immunology · R01 · FY2019 · HL
The Oral Microbiome in Type 1 Diabetes and Sub-Clinical Cardiovascular Disease
$628,233Amy Christine Alman · University Of South Florida · R01 · FY2017 · DE
Whole Genome RNA Sequencing (RNAseq) of Blood from Patients with Lacunar Stroke
$628,167Frank R Sharp · University Of California At Davis · R01 · FY2017 · NS
Biophysics of HDL Dysfunction
$628,118Kirkwood A Pritchard · Medical College Of Wisconsin · R01 · FY2013 · HL
Sex-Specific Roles of L-PK in Cholesterol Metabolism and Atherosclerosis
$628,115Karthickeyan Chella Krishnan · University Of Cincinnati · R01 · FY2025 · HL
Cardiovascular Health Effects of the Great Recession
$628,085Teresa E Seeman · University Of California Los Angeles · R01 · FY2020 · AG
A Neurobehavioral Family Study of Schizophrenia
$627,741University Of Pennsylvania · R01 · FY2004 · MH
Aspirin-triggered Specialized Pro-resolving Mediators in Increasing Weight and Atherosclerotic Cardiovascular Disease
$627,717Sean Patrick Heffron · New York University School Of Medicine · R01 · FY2024 · HL
Epidemiology: Oxidative Stress and Early Atherosclerosis
$627,648David R Jacobs · University Of Minnesota · R01 · FY2007 · HL
HIGH FREQUENCY NONLINEAR ACOUSTIC INTRAVASCULAR IMAGING
$627,574Cleveland Clinic Lerner Col/Med-Cwru · R01 · FY2004 · HL
Validation of Circulating Endothelial Cells and Microparticles in Youth
$627,480Aaron S Kelly · University Of Minnesota · R01 · FY2014 · HL
A Smart Ring for Cuffless Blood Pressure to Reduce Health Disparities in People of Color
$627,449Roozbeh Jafari · Massachusetts Institute Of Technology · R01 · FY2024 · EB
Magnetically activated structures for minimally invasive endovascular therapy
$627,342Chander Sadasivan · State University New York Stony Brook · R21 · FY2021 · EB
Progression of sub-clinical Atherosclerosis
$627,252Tufts Medical Center · R01 · FY2005 · HL
Inflammation and delayed cognitive dysfunction after stroke
$627,236Kristian Paul Doyle · University Of Arizona · R56 · FY2022 · NS
PORCINE MODELS OF CORONARY ARTERY DISEASE IN DIABETES
$627,208Indiana Univ-Purdue Univ At Indianapolis · R24 · FY2005 · RR
The role of eosinophil in thrombosis and atherosclerosis in LNK deficiency
$627,174Nan Wang · Columbia University Health Sciences · R01 · FY2024 · HL
Lipid raft therapy â a novel therapeutic approach for HIV-associated cardiometabolic co-morbidities
$627,036Michael Ilya Bukrinsky · George Washington University · R01 · FY2024 · HL
Epidemiology of blood pressure responses to perturbations: Correlates and prognosis for vascular risk, end-organ damage, cognitive aging and preclinical Alzheimer's disease
$627,006Vasan S. Ramachandran · University Of Texas Hlth Science Center · R01 · FY2023 · AG
CSDE1 as a Post Transcriptional Regulator of the LDLR
$626,993John S Chorba · University Of California, San Francisco · R01 · FY2022 · HL
Licensing LncRNAs in Atherosclerosis
$626,961Tamer Sallam · University Of California Los Angeles · R01 · FY2021 · HL
Licensing LncRNAs in Atherosclerosis
$626,961Tamer Sallam · University Of California Los Angeles · R01 · FY2023 · HL
Licensing LncRNAs in Atherosclerosis
$626,961Tamer Sallam · University Of California Los Angeles · R01 · FY2022 · HL